Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
1.170
+0.010 (0.86%)
At close: Mar 28, 2025, 4:00 PM
1.209
+0.039 (3.30%)
After-hours: Mar 28, 2025, 6:20 PM EDT
Gossamer Bio Revenue
In the year 2024, Gossamer Bio had annual revenue of $114.70M. Gossamer Bio had revenue of $9.38M in the quarter ending December 31, 2024.
Revenue (ttm)
$114.70M
Revenue Growth
n/a
P/S Ratio
2.31
Revenue / Employee
$791,041
Employees
145
Market Cap
265.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGOSS News
- 16 days ago - Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - Business Wire
- 21 days ago - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Gossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILD - Seeking Alpha
- 7 weeks ago - Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 2 months ago - Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 5 months ago - Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 7 months ago - Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
- 7 months ago - Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire